| Popis: |
Background Race is linked to delays in healthcare. Black and Hispanic patients with osteoarthritis have worse pain and function than Whites before arthroplasty. Whether Black and Hispanic patients with RA similarly delay care is unknown. Objectives To assess whether Black and/or Hispanic (minority) RA patients have worse pain, function and disease activity at the time of arthroplasty. Methods We used prospectively acquired data on RA patients between 10/2013 and 11/2018 prior to total knee arthroplasty (TKA) or total hip arthroplasty (THA). Pain, function, and disease activity were assessed using the visual analogue scale (VAS), the Multidimensional Health Assessment Questionnaire (MD HAQ), and the Disease Activity Score (DAS28). Race, ethnicity, education, income, insurance and medications were collected via self-report questionnaire. Multivariable linear and logistic models examined whether minority status predicted pain, function and disease activity. Results 37 (23%) of the 164 patients were minorities (Table 1). MD HAQ and DAS28 were worse in minorities, only VAS was significant (p-value= 0.029). There was no significant difference in education. Unadjusted comparisons indicated no difference in pain, function, disease activity or medication use between groups. Insurance varied significantly between groups (p= Conclusion For Black and/or Hispanics with RA undergoing THA or TKA at a high-volume specialty hospital, minority status was not significantly associated with pain, disability or RA disease activity at the time of elective arthroplasty. Disclosure of Interests Julianna Hirsch: None declared, Bella Mehta: None declared, Jackie Finik: None declared, Serene Mirza: None declared, Mark Figgie: None declared, Collin Brantner: None declared, Iris Navarro-Millan: None declared, Susan Goodman Grant/research support from: Novartis: research support, Consultant for: Novartis, UCB, Pfizer: consulting |
